Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Flavonoid aglycones can compete with Ochratoxin A for human serum albumin : a new possible mode of action (CROSBI ID 202019)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Poór, Miklós ; Kunsági-Máté, Sándor ; Bencsik, Tímea ; Petrik, Jozsef ; Vladimir-Knežević, Sanda ; Kőszegi, Tamás Flavonoid aglycones can compete with Ochratoxin A for human serum albumin : a new possible mode of action // International journal of biological macromolecules, 51 (2012), 3; 279-283. doi: 10.1016/j.ijbiomac.2012.05.019

Podaci o odgovornosti

Poór, Miklós ; Kunsági-Máté, Sándor ; Bencsik, Tímea ; Petrik, Jozsef ; Vladimir-Knežević, Sanda ; Kőszegi, Tamás

engleski

Flavonoid aglycones can compete with Ochratoxin A for human serum albumin : a new possible mode of action

The mycotoxin Ochratoxin A (OTA) appears worldwide in cereals, plant products, different foods and drinks. Ochratoxin A binds to plasma albumin with a very high affinity. However, it is well known that natural flavonoids can also bind to human serum albumin (HSA) at the same binding site as OTA does (site I, subdomain IIA). A few experimental literature data suggest that reducing the bound fraction of OTA speeds up its elimination rate with a potential decrease in its toxicity. In our experimental model competitive binding properties of flavonoid aglycones were examined with a fluorescence polarization based approach. Our data show that some of the flavonoids are able to remove the toxin from HSA. We conclude that among the 13 studied flavonoid aglycones galangin and quercetin were the most effective competitors for OTA.

flavonoids; Ochratoxin A; Competitive interaction; Human serum albumin; Fluorescence polarization

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

51 (3)

2012.

279-283

objavljeno

0141-8130

10.1016/j.ijbiomac.2012.05.019

Povezanost rada

Farmacija

Poveznice
Indeksiranost